Eliem Therapeutics Inc.

NASDAQ: ELYM · Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM

Eliem Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-73.9M -35.12M -45.24M -47.48M
Depreciation & Amortization
-757K n/a n/a 1.84M
Stock-Based Compensation
5.56M 12.81M 6.99M 3.74M
Other Working Capital
n/a 4.45M 863K -4.32M
Other Non-Cash Items
n/a -2.05M 2.06M 11.84M
Deferred Income Tax
n/a n/a -1.39M -1.84M
Change in Working Capital
n/a 3.76M 210K -4.17M
Operating Cash Flow
-15.56M -20.6M -37.37M -36.07M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
-4.64M n/a n/a n/a
Purchase of Investments
-132.2M -58.45M -87.96M -114.97M
Sales Maturities Of Investments
20.75M 127.43M 122.4M n/a
Other Investing Acitivies
-5M 68.98K 34.44K -114.97K
Investing Cash Flow
-121.09M 68.98M 34.44M -114.97M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
10.98M 841K n/a 149K
Financial Cash Flow
130.73M 841K n/a 177.23M
Net Cash Flow
-5.88M 49.53M -3.34M 26.43M
Free Cash Flow
-15.56M -20.6M -37.37M -36.07M